Total Payments
$3,898
2024 Payments
$478.70
Companies
46
Transactions
260
Medicare Patients
467
Medicare Billing
$12,012
Payment Breakdown by Category
Food & Beverage$3,801 (97.5%)
Consulting$50.00 (1.3%)
Education$47.11 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,801 | 257 | 97.5% |
| Consulting Fee | $50.00 | 1 | 1.3% |
| Education | $47.11 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $455.20 | 36 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $399.87 | 28 | $0 (2022) |
| Novo Nordisk Inc | $378.88 | 21 | $0 (2024) |
| ABBVIE INC. | $373.12 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $317.40 | 16 | $0 (2024) |
| Allergan, Inc. | $296.95 | 26 | $0 (2020) |
| PFIZER INC. | $208.92 | 16 | $0 (2024) |
| Amgen Inc. | $160.32 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $134.41 | 10 | $0 (2023) |
| Alkermes, Inc. | $119.29 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.70 | 28 | ABBVIE INC. ($91.02) |
| 2023 | $524.63 | 34 | AbbVie Inc. ($148.87) |
| 2022 | $439.61 | 28 | ABBVIE INC. ($71.44) |
| 2021 | $405.41 | 20 | Novo Nordisk Inc ($144.21) |
| 2020 | $214.36 | 14 | Sunovion Pharmaceuticals Inc. ($45.33) |
| 2019 | $613.67 | 48 | Lilly USA, LLC ($139.95) |
| 2018 | $767.01 | 53 | Sunovion Pharmaceuticals Inc. ($138.87) |
| 2017 | $454.89 | 35 | Lilly USA, LLC ($65.91) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardio-renal | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: PAIN | ||||||
| 05/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Respiratory | ||||||
| 03/20/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: ETONOGESTREL | ||||||
| 03/20/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: ETONOGESTREL | ||||||
| 02/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Oncology | ||||||
| 02/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 142 | 165 | $3,830 | $1,525 |
| 2022 | 5 | 122 | 156 | $6,561 | $2,609 |
| 2021 | 8 | 151 | 217 | $16,927 | $7,410 |
| 2020 | 3 | 52 | 65 | $2,050 | $467.05 |
Total Patients
467
Total Services
603
Medicare Billing
$12,012
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 47 | 47 | $1,222 | $799.94 | 65.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 30 | 43 | $1,478 | $409.36 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 41 | $246.00 | $241.08 | 98.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 34 | $884.00 | $74.80 | 8.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 22 | $2,442 | $1,174 | 48.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 11 | 11 | $1,815 | $866.40 | 47.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 27 | 34 | $1,190 | $327.06 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 60 | $360.00 | $177.69 | 49.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 29 | $754.00 | $64.21 | 8.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 56 | $6,216 | $2,993 | 48.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 16 | $4,960 | $2,425 | 48.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 13 | 14 | $2,310 | $1,125 | 48.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 34 | 50 | $1,750 | $485.50 | 27.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 11 | 12 | $444.00 | $160.68 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 27 | 29 | $174.00 | $87.00 | 50.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 11 | 11 | $319.00 | $68.53 | 21.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 23 | 29 | $754.00 | $65.25 | 8.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 27 | 35 | $1,225 | $339.85 | 27.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 13 | 15 | $435.00 | $93.45 | 21.5% |
| 81003 | Automated urinalysis test | Office | 2020 | 12 | 15 | $390.00 | $33.75 | 8.7% |
About Yolanda Yoder, M. D
Yolanda Yoder, M. D is a Addiction Medicine healthcare provider based in Paoli, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730298746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yolanda Yoder, M. D has received a total of $3,898 in payments from pharmaceutical and medical device companies, with $478.70 received in 2024. These payments were reported across 260 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($3,801).
As a Medicare-enrolled provider, Yoder has provided services to 467 Medicare beneficiaries, totaling 603 services with total Medicare billing of $12,012. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Family Medicine
- Location Paoli, IN
- Active Since 08/30/2006
- Last Updated 12/10/2020
- Taxonomy Code 207QA0401X
- Entity Type Individual
- NPI Number 1730298746
Products in Payments
- LATUDA (Drug) $386.04
- VRAYLAR (Drug) $327.74
- TRULICITY (Drug) $246.22
- BREZTRI (Drug) $133.77
- FARXIGA (Drug) $131.00
- RYBELSUS (Drug) $125.00
- MOUNJARO (Drug) $124.27
- UBRELVY (Drug) $108.80
- CHANTIX (Drug) $98.89
- NURTEC ODT (Drug) $92.02
- VIBERZI (Drug) $89.87
- Victoza (Drug) $88.23
- TRELEGY ELLIPTA (Drug) $80.98
- LINZESS (Drug) $73.99
- Kerendia (Drug) $71.45
- CAPLYTA (Drug) $68.00
- ARISTADA (Drug) $67.75
- Ozempic (Drug) $66.21
- Otezla (Drug) $59.26
- EMGALITY (Drug) $57.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.